Dystrophin: the protein product of the Duchenne muscular dystrophy locus - PubMed (original) (raw)
Dystrophin: the protein product of the Duchenne muscular dystrophy locus
E P Hoffman et al. Cell. 1987.
Abstract
The protein product of the human Duchenne muscular dystrophy locus (DMD) and its mouse homolog (mDMD) have been identified by using polyclonal antibodies directed against fusion proteins containing two distinct regions of the mDMD cDNA. The DMD protein is shown to be approximately 400 kd and to represent approximately 0.002% of total striated muscle protein. This protein is also detected in smooth muscle (stomach). Muscle tissue isolated from both DMD-affected boys and mdx mice contained no detectable DMD protein, suggesting that these genetic disorders are homologous. Since mdx mice present no obvious clinical abnormalities, the identification of the mdx mouse as an animal model for DMD has important implications with regard to the etiology of the lethal DMD phenotype. We have named the protein dystrophin because of its identification via the isolation of the Duchenne muscular dystrophy locus.
Similar articles
- The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle.
Zubrzycka-Gaarn EE, Bulman DE, Karpati G, Burghes AH, Belfall B, Klamut HJ, Talbot J, Hodges RS, Ray PN, Worton RG. Zubrzycka-Gaarn EE, et al. Nature. 1988 Jun 2;333(6172):466-9. doi: 10.1038/333466a0. Nature. 1988. PMID: 3287171 - Unraveling the mysteries of Duchenne and Becker muscular dystrophy.
Hyser CL. Hyser CL. Mol Chem Neuropathol. 1989 Feb;10(1):15-20. doi: 10.1007/BF02969482. Mol Chem Neuropathol. 1989. PMID: 2660836 Review. - [Presence of dystrophine-like protein at the neuromuscular junction in Duchenne muscular dystrophy and in "mdx" mutant mice].
Fardeau M, Tomé FM, Collin H, Augier N, Pons F, Léger J, Léger J. Fardeau M, et al. C R Acad Sci III. 1990;311(5):197-204. C R Acad Sci III. 1990. PMID: 2119867 French. - Normal and dystrophin-deficient muscle fibers in carriers of the gene for Duchenne muscular dystrophy.
Bonilla E, Schmidt B, Samitt CE, Miranda AF, Hays AP, de Oliveira AB, Chang HW, Servidei S, Ricci E, Younger DS, et al. Bonilla E, et al. Am J Pathol. 1988 Dec;133(3):440-5. Am J Pathol. 1988. PMID: 3059802 Free PMC article. - The molecular basis of activity-induced muscle injury in Duchenne muscular dystrophy.
Petrof BJ. Petrof BJ. Mol Cell Biochem. 1998 Feb;179(1-2):111-23. doi: 10.1023/a:1006812004945. Mol Cell Biochem. 1998. PMID: 9543354 Review.
Cited by
- Safety and efficacy of viltolarsen in ambulatory and nonambulatory males with Duchenne muscular dystrophy.
Harper AD, Topaloglu H, Mercuri E, Suslov V, Wu L, Ayanoglu CY, Tansey M, Previtera ML, Crozier RA, Magnus L, Clemens PR. Harper AD, et al. Sci Rep. 2024 Oct 8;14(1):23488. doi: 10.1038/s41598-024-70783-y. Sci Rep. 2024. PMID: 39379403 Free PMC article. Clinical Trial. - CRISPR-mediated megabase-scale transgene de-duplication to generate a functional single-copy full-length humanized DMD mouse model.
Chey YCJ, Corbett MA, Arudkumar J, Piltz SG, Thomas PQ, Adikusuma F. Chey YCJ, et al. BMC Biol. 2024 Sep 27;22(1):214. doi: 10.1186/s12915-024-02008-7. BMC Biol. 2024. PMID: 39334101 Free PMC article. - Cell transplantation-mediated dystrophin supplementation efficacy in Duchenne muscular dystrophy mouse motor function improvement demonstrated by enhanced skeletal muscle fatigue tolerance.
Bourgeois Yoshioka CK, Takenaka-Ninagawa N, Goto M, Miki M, Watanabe D, Yamamoto M, Aoyama T, Sakurai H. Bourgeois Yoshioka CK, et al. Stem Cell Res Ther. 2024 Sep 19;15(1):313. doi: 10.1186/s13287-024-03922-x. Stem Cell Res Ther. 2024. PMID: 39300595 Free PMC article. - Distribution of MRI-derived T2 values as a biomarker for in vivo rapid screening of phenotype severity in mdx mice.
Waters EA, Haney CR, Vaught LA, McNally EM, Demonbreun AR. Waters EA, et al. PLoS One. 2024 Sep 19;19(9):e0310551. doi: 10.1371/journal.pone.0310551. eCollection 2024. PLoS One. 2024. PMID: 39298449 Free PMC article. - Correction of exon 2, exon 2-9 and exons 8-9 duplications in DMD patient myogenic cells by a single CRISPR/Cas9 system.
Lemoine J, Dubois A, Dorval A, Jaber A, Warthi G, Mamchaoui K, Wang T, Corre G, Bovolenta M, Richard I. Lemoine J, et al. Sci Rep. 2024 Sep 11;14(1):21238. doi: 10.1038/s41598-024-70075-5. Sci Rep. 2024. PMID: 39261505 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases